The Excerpt podcast

SPECIAL | Why Americans are making homegrown GLP-1s

15/10/2025
0:00
13:15
Manda indietro di 15 secondi
Manda avanti di 15 secondi

High costs. Limited supply. No insurance coverage. All of these are motivating some patients to cook up unregulated “gray GLP-1” drugs at home. Health experts are worried. Why are people willing to risk injecting homemade drugs in an unregulated, non-sterile medical environment and what needs to change before access and safety improve? USA TODAY Wellness Reporter Nicole Fallert joins The Excerpt to share her reporting on this alarming trend.

Have feedback on the show? Please send us an email at [email protected].

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Altri episodi di "The Excerpt"